ACRS FY 2023 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$435M

FY 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$31M+5.0% YoY

Gross Profit

$13M42.1% margin

Operating Income

-$97M-311.6% margin

Net Income

-$88M-283.1% margin

EPS (Diluted)

$-1.27

Cash Flow

Operating Cash Flow

-$78M

Free Cash Flow

-$80M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$197M

Total Liabilities

$40M

Stockholders' Equity

$157M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$30M	+5.0%
Gross Profit	$13M	$18M	-26.0%
Operating Income	-$97M	-$90M	-8.4%
Net Income	-$88M	-$87M	-1.8%